FzioMed Appoints Ron Ehmsen as Vice President of Clinical Affairs

SAN LUIS OBISPO, California – October 19, 2005 – FzioMed, Inc. announced today the expansion of its senior management team with the appointment of Ronald J. Ehmsen, ScD as Vice President of Clinical Affairs.

Dr. Ehmsen will be responsible for overall planning and direction of the company’s clinical research activities and for ensuring the effective execution of all domestic and international clinical programs. “FzioMed has an impressive pipeline of new products and I am excited to join the talented team of professionals here,” Ron said today.

Ron has more than twenty-five years of executive experience in research and development and clinical and regulatory affairs in the medical device industry. Ron most recently held the position of Senior Vice President of Global Clinical and Regulatory Affairs at Inamed Corporation. His experience includes senior positions in leading medical device corporations, including Senior Director of Regulatory Affairs for Tyco Mallinckrodt; Corporate Vice President of Regulatory Affairs for Circon Corporation; President of Optimed Technologies; and Vice President of Regulatory Affairs, Quality Assurance and Clinical Programs for American Hospital Supply Corporation. Ron holds a Doctor of Science degree in Chemical Engineering from Washington University in St. Louis, a Master’s degree from Purdue University and a Bachelor’s degree from New York University.

“We are very pleased to welcome Ron to the FzioMed team,” said John Krelle, President and Chief Operating Officer for FzioMed. “Ron’s extensive background in directing global clinical operations and his experience in surgical biomaterials will be key contributors to our successful growth.”

About FzioMed

FzioMed is a privately held medical company engaged in the development and commercialization of synthetic, absorbable biomaterials based on the company’s patented Oxiplex technology. FzioMed is developing products for adhesion prevention, tissue augmentation and regeneration, and the delivery of drugs. Oxiplex is an innovative polymer technology with uses in a variety of specialties including orthopedics, gynecology, general surgery, neurosurgery and aesthetic surgery. FzioMed products include Oxiplex/SP, the leading adhesion barrier for spine surgery currently marketed outside of the United States, Oxiplex/AP adhesion barrier for gynecologic and general surgery, and a cosmetic dermal filler.

FzioMed® and Oxiplex® are registered trademarks of FzioMed, Inc.